Literature DB >> 11826218

Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

.   

Abstract

This statement is intended for health care professionals caring for neonates and young infants. The objectives of this statement are to review the short- and long-term effects of systemic and inhaled postnatal corticosteroids for the prevention or treatment of evolving or established chronic lung disease and to make recommendations for the use of corticosteroids in infants with very low birth weight. The routine use of systemic dexamethasone for the prevention or treatment of chronic lung disease in infants with very low birth weight is not recommended.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11826218     DOI： 10.1542/peds.109.2.330

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


  85 in total

1.  Post-natal corticosteroid use.

Authors:  Olivia Williams; Anne Greenough
Journal:  Eur J Pediatr       Date:  2003-07-16       Impact factor: 3.183

Review 2.  Changing trends in the management of respiratory distress syndrome (RDS).

Authors:  Praveen Kumar; P S Sandesh Kiran
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

3.  Pediatric Respiratory Assembly. Mini symposium on lung inflammation.

Authors:  Larry C Lands; A Keith Tanswell; Sophie Laberge; Christine McCusker; Felix Ratjen
Journal:  Can Respir J       Date:  2010 Mar-Apr       Impact factor: 2.409

Review 4.  Respiratory complications of preterm birth.

Authors:  Jenny Fraser; Moira Walls; William McGuire
Journal:  BMJ       Date:  2004-10-23

Review 5.  Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use.

Authors:  David G Grier; Henry L Halliday
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  Jason Gien; John P Kinsella
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

Review 7.  Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Wes Onland; Anne Pmc De Jaegere; Martin Offringa; Anton van Kaam
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

8.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop.

Authors:  Rosemary D Higgins; Alan H Jobe; Marion Koso-Thomas; Eduardo Bancalari; Rose M Viscardi; Tina V Hartert; Rita M Ryan; Suhas G Kallapur; Robin H Steinhorn; Girija G Konduri; Stephanie D Davis; Bernard Thebaud; Ronald I Clyman; Joseph M Collaco; Camilia R Martin; Jason C Woods; Neil N Finer; Tonse N K Raju
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

Review 9.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Early cortisol values and long-term outcomes in extremely low birth weight infants.

Authors:  S W Aucott; K L Watterberg; M L Shaffer; P K Donohue
Journal:  J Perinatol       Date:  2009-12-10       Impact factor: 2.521
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.